Navigation Links
Mast Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/4/2013

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended September 30, 2013.

Brian M. Culley, Chief Executive Officer, said: "We continue to focus on EPIC, our pivotal phase 3 study of MST-188 in sickle cell disease.  We almost doubled the number of open clinical sites since the end of the second quarter and are approaching our goal of opening 40 clinical sites in the U.S. Beginning next year, we also plan to open approximately 30 clinical sites outside the U.S."

Mr. Culley continued: "In addition to sickle cell disease, we are evaluating MST-188 in other areas of significant unmet medical need and plan to initiate a 60-patient phase 2 study in acute limb ischemia in early 2014.  This study will determine whether MST-188 improves the effectiveness of existing thrombolytic agents, such as Activase®, a tissue plasminogen activator (tPA) that is approved to treat stroke, heart attack and pulmonary embolism.  If our phase 2 study demonstrates that MST-188 improves the 'clot busting' activity of tPA, we believe it will open the door to developing MST-188 in combination with tPA in all settings in which thrombolytics are used, most notably stroke." 

Third Quarter 2013 Operating ResultsThe Company's net loss for the third quarter of 2013 was $5.3 million, or $0.05 per share (basic and diluted), compared to a net loss of $3.2 million, or $0.07 per share (basic and diluted), for the same period in 2012.

Research and development (R&D) expenses for the third quarter of 2013 were $3.1 million, an increase of $1.4 million, or 87%, compared to $1.7 million for the same period in 2012. The increase was primarily due to increases of $1.3 million in external clinical study fees and expenses and $
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
2. Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday, November 7, 2013
3. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
4. Cell Therapeutics Reports Third Quarter 2013 Financial Results
5. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
6. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
7. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
8. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
9. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
10. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
11. Aratana Therapeutics Adds to Commercial Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Kewaunee Scientific Corporation ... of Directors increased its quarterly cash dividend by 9% ... per outstanding share, beginning with the dividend payable on ... close of business on September 8, 2014. ... in 1906, Kewaunee Scientific Corporation is a recognized global ...
(Date:8/27/2014)... -- Columbia Laboratories, Inc. (Nasdaq: CBRX ) ("Columbia" ... trial manufacturing, and advanced analytical and consulting services to ... at the upcoming Rodman & Renshaw 16 th ... New York . The Company will present ... at the New York Palace Hotel. ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... N.J., Feb. 15, 2011 Daiichi Sankyo, Inc. (DSI), ... facility in Bethlehem Township, Pennsylvania from Amcor, a global ... leverage existing resources to more cost-effectively supplement its operations ... expected to be operational in the summer or early ...
... MAHWAH, N.J., Feb. 15, 2011 Stryker Corporation,s Orthopaedics ... most recognizable names and personalities in professional golf, has ... of the sport and current member of the PGA ... Triathlon ® Knee System in November 2009 and ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 2Fred Funk Becomes Spokesperson for Stryker Orthopaedics 3
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 ... small and mid-sized healthcare organizations, today announced that it ... online appointment company ZocDoc , to head their ... company has created a sales management position. , “I’m ... startup like DoctorBase that already has so much traction ...
(Date:8/28/2014)... August 28, 2014 Top 10 ... web hosting companies and announces Bluehost, HostMonster ( ... suppliers for the webmasters worldwide who want to ... , As the world’s most popular server-side scripting ... many other general-purpose programs. It is now installed ...
(Date:8/28/2014)... MarijuanaDoctors.com is enthralled to announce the ... of Livermore, California. As always, MarijuanaDoctors.com prides itself on ... and in accordance with that, we are excited to ... practice. , Initially finding his calling for healing and ... was shaped by his mother’s severe arthritis to finally ...
(Date:8/28/2014)... The revenue cycle process touches on nearly ... a patient books an appointment with a physician’s office, ... for services rendered to the healthcare provider. Medorizon ... the RCM process down to a science. Over the ... place in nearly every healthcare facility around the globe. ...
(Date:8/28/2014)... The next episode of “Extreme Weight Loss” ... He’s a drama coach who longs to audition for ... achieving that dream impossible. , Featuring a unique, non-competitive ... Tuesday, September 2 (9:00-11:00 p.m., ET/PT) on the ABC ... smile on the outside to hide the self-doubt and ...
Breaking Medicine News(10 mins):Health News:DoctorBase Hires Josh Angeles as Vice-President of Sales 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:“Extreme Weight Loss”: Rod’s Journey Begins at the University of Colorado Anschutz Health and Wellness Center 2
... January 14, 2009 Obesity continues to increase for ... Mexican-American women. Between the ages of 35-44, there are ... and 575,000 Mexican-American women who are obese. A new ... reveals that there is an increased risk for ...
... LIVONIA, Mich., Jan. 14 On the heels of ... 11 states, American Community,Mutual Insurance Company today announced that ... Indiana. Designed to help consumer,s hold,down their medical expenses, ... through independent agents for a coverage effective date beginning,March ...
... much about it. FlameEz.com is launched to provide the latest information ... of the most feared illnesses in middle and old age. ... ... Millions of Americans are affected by chronic inflammation without knowing much ...
... SHANGHAI, China, Jan. 14 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... Company"), a leading Chinese firm,specializing in the ... products, today announced it has signed contracts,with ... Co., Ltd. ("Yuejia Food"),Shandong Huwa Dairy Industry ...
... N.Y., Jan. 14 /PRNewswire/ -- Scarguard Labs, ... of scars and other dermatological problems through the use ... system, announced it has appointed Richard E. Pino as ... Company,s finance, accounting, and treasury functions and will report ...
... in outbreak rises to 425 in 43 states, CDC says ... of people sickened by salmonella-contaminated peanut butter rose to 425 ... death in Minnesota and two in Virginia were probably tied ... the three people, whose names and hometowns haven,t been released, ...
Cached Medicine News:Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:American Community Introduces Community Flex(TM), an Affordable Health Plan in Arizona and Indiana 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4Health News:Scarguard Labs, LLC Appoints Richard E. Pino as CFO 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 3
... Chalam 15° Prism are designed ... are recommended for tractional retinal ... Rhegmatogenus retinal detachment. They can ... and other midperipheral laser applications. ...
... The High-Mag 1.5x ... internal limiting membrane peeling ... optic nerve neurotomy, sheathotomy ... traditional macular edema and ...
... visualization of virtually the entire retina including ... of the lens on the eye. It ... giant retinal tears, diagnosing and treating anterior ... retina in a vitreous cavity filled with ...
... higher magnification and increased stereopsis, ... suited for detailed visualization to ... Retinal is ideal for vitrectomy ... peeling in proliferative vitreoretinopathy extending ...
Medicine Products: